D3-Pharmacy Aps: Financial statements 2025
CVR: 71087611
Source: annual report 2025, Danish Business Authority
01/10/2024 – 30/09/2025
D3-Pharmacy Aps (CVR 71087611) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -2,710 and a net result of DKK -4,037 compared with DKK -13,135 the year before. Equity in the 2025 report amounted to DKK 526,147. The solvency ratio was 100%.
- Gross Profit
- DKK -2,710
- Profit/Loss
- DKK -4,037
- Equity
- DKK 526,147
- Total Assets
- DKK 526,147
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -3 t. | -4 t. | 526 t. | - |
| 2024 | - | -12 t. | -13 t. | 530 t. | - |
| 2023 | - | -11 t. | -6 t. | 543 t. | 1 |
| 2022 | - | -10 t. | -18 t. | 549 t. | 1 |
| 2021 | - | -3 t. | -7 t. | 567 t. | 1 |
Official annual report
How creditworthy is D3-Pharmacy Aps?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
D3-Pharmacy Aps has published its annual report for 2024. Gross profit came to DKK -12,310, and the net result was DKK -13,135.
About D3-Pharmacy Aps
D3-Pharmacy Aps is a Danish company of the type Anpartsselskab based in Svenstrup J, founded in 1982. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Finn Jørgen Jensen. The company is owned by Finn Jørgen Jensen. According to the 2023 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -2,710 and a net result of DKK -4,037 compared with DKK -13,135 the year before. Equity in the 2025 report amounted to DKK 526,147.